Related Experiment Video
Updated: Feb 19, 2026
MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR
Published on: May 16, 2012
The miRNA Pull Out Assay as a Method to Validate the miR-28-5p Targets Identified in Other Tumor Contexts in Prostate
Milena Rizzo1,2, Gabriele Berti1,3, Francesco Russo4,5
1Non-coding RNA Laboratory, Institute of Clinical Physiology (IFC), CNR, Via Moruzzi 1, 56124 Pisa, Italy.
Abstract:
miR-28-5p is an intragenic miRNA which is underexpressed in several tumor types showing a tumor suppressor (TS) activity. Routinely, the known miR-28-5p targets are validated in specific tumor contexts but it is unclear whether these targets are also being regulated in other tumor types. To this end, we adopted the miRNA pull out assay to capture the miR-28-5p targets in DU-145 prostate cancer (PCa) cells. Firstly, we demonstrated that miR-28-5p acts as a TS-miRNA in PCa, affecting cell proliferation, survival, and apoptosis. Secondly, we evaluated the enrichment of the 10 validated miR-28-5p targets in the pull out sample. We showed that E2F6, TEX-261, MAPK1, MPL, N4BP1, and RAP1B but not BAG1, OTUB1, MAD2L1, and p21 were significantly enriched, suggesting that not all the miR-28-5p targets are regulated by this miRNA in PCa. We then verified whether the miR-28-5p-interacting targets were regulated by this miRNA. We selected E2F6, the most enriched target in the pull out sample, and demonstrated that miR-28-5p downregulated E2F6 at the protein level suggesting that our approach was effective. In general terms, these findings support the miRNA pull out assay as a useful method to identify context-specific miRNA targets.
Insights
MicroRNA-28-5p acts as a tumor suppressor in prostate cancer. A novel pull-out assay identified context-specific targets, revealing miR-28-5p regulates E2F6 protein levels.
Area of Science:
- Molecular Biology
- Oncology
- Gene Regulation
Background:
- MicroRNA-28-5p (miR-28-5p) exhibits tumor suppressor activity across various cancers.
- Known miR-28-5p targets require validation in specific cancer contexts, as regulation may vary.
- The role and specific targets of miR-28-5p in prostate cancer (PCa) remain incompletely understood.
Purpose of the Study:
- To investigate the tumor suppressor role of miR-28-5p in prostate cancer.
- To identify context-specific direct targets of miR-28-5p in PCa cells.
- To validate the efficacy of the miRNA pull-out assay for target identification.
Main Methods:
- Utilized the miRNA pull-out assay to capture endogenous miR-28-5p targets in DU-145 PCa cells.
- Assessed the impact of miR-28-5p on PCa cell proliferation, survival, and apoptosis.
- Quantified the enrichment of known miR-28-5p targets in pull-out samples and validated protein-level regulation of E2F6.
Main Results:
- miR-28-5p demonstrated significant tumor suppressor activity in PCa, inhibiting proliferation and promoting apoptosis.
- Six validated targets (E2F6, TEX-261, MAPK1, MPL, N4BP1, RAP1B) were significantly enriched, while four were not.
- miR-28-5p was confirmed to downregulate E2F6 protein expression, validating the assay's effectiveness.
Conclusions:
- miR-28-5p functions as a tumor suppressor in prostate cancer.
- The miRNA pull-out assay is effective for identifying context-specific miRNA targets.
- Not all previously validated miR-28-5p targets are regulated in the context of prostate cancer.
Related Concept Videos
01:22MicroRNAs
01:22MicroRNAs